跳至主要内容
临床试验/NCT05546112
NCT05546112尚未招募不适用

Pilot Study to Explore the Efficacy and Safety of At-home Transcutaneous Electrical Nerve Stimulation in Insomnia

Ybrain Inc.0 个研究点目标入组 30 人开始时间: 2022年10月4日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Ybrain Inc.
入组人数
30
主要终点
Changes in Insomnia Severity Index (ISI)

研究概览

简要总结

The purpose of this study is to explore the effects and safety of transcutaneous electrical nerve stimulation (TENS) at home for patients diagnosed with insomnia on the improvement of insomnia and nervous stability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women between the ages of 19 and under 65
  • Those who meet the criteria for the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) for Insomnia
  • Those with a score of 8 or higher based on the Korean version Insomnia severity index (ISI-K)
  • A person whose sleeping environment and habits are regular, usually between 9:00 p.m. and 1:00 a.m., go to bed, lie down for 7 to 10 hours, and wake up between 5 and 10 a.m.
  • In the case of patients who regularly take drugs for improving insomnia at least once a week, those who agree to discontinue taking the prohibited drugs in this study for a total of 5 weeks, 1 week to remove the drug effect after screening and 4 weeks for the clinical study period
  • Persons who do not have a reason to prohibit the use of electrotherapy that can significantly affect biomarkers in relation to this study
  • A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing and understanding a sufficient explanation about this clinical trial

排除标准

  • Those who have been diagnosed with sleep arousal disorders other than insomnia (hypersomnia disorder, narcolepsy, breathing-related sleep disorder, circadian rhythm sleep arousal disorder, parasomnia)
  • Those who have insomnia due to physical illness or medications being taken
  • Patients with major medical and neuropsychiatric diseases other than sleep disorders
  • Persons who have had or are currently undergoing dental treatment with a history of implanting metallic materials into the upper body, such as the transcranial or face, neck, etc., where non-invasive electrical stimulation is difficult or impossible
  • Compliance was evaluated by writing a sleep diary for 1 week from the start of treatment, and if a sleep diary of 3 days or less was kept for 1 week, it was excluded from the study.
  • Those who have changed the type and dose of drugs used within the last 3 months, or the type and time of cognitive behavioral therapy
  • If you are currently registered in another clinical trial or use another clinical trial drug or device within 60 days from the time of screening
  • Exclusion criteria prior to intervention (After the sleep diary for one week after the screening test, if the following criteria are met, the patient will be excluded from participation in the study before the intervention.)
  • Those with less than 8 points based on the Korean version of Insomnia severity index (ISI-K)
  • When writing a sleep diary for a week, if it is written for less than 3 days or has an irregular sleep schedule

结局指标

主要结局

Changes in Insomnia Severity Index (ISI)

时间窗: after 4 weeks

Changes in Insomnia Severity Index (ISI) after 4 weeks from pretreatment:

次要结局

  • Remission rate of ISI(after 4 weeks)
  • Changes in Pittsburgh Slepp Quality Index (PSQI)(after 4 weeks)
  • Changes in index of slepp diary(after 4 weeks)
  • Changes in EEG index(after 4 weeks)
  • Response rate of ISI(after 4 weeks)

研究者

发起方
Ybrain Inc.
申办方类型
Industry
责任方
Sponsor

相似试验

The Efficacy and Safety of At-home Transcutaneous... | 临床试验